Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836643 | PMC |
| http://dx.doi.org/10.36416/1806-3756/e20210304 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prospective Evaluation of Thrombotic Complications After Internal Jugular Vein Cannulation for External Bypass.
J Cardiothorac Vasc Anesth
August 2025
Goethe-University Frankfurt, University Hospital Frankfurt, Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, Frankfurt, Germany; Department of Anesthesiology and Intensive Care Medicine, Rheinische Friedrich-Wilhelms-University, University Hospital Bonn, Bonn, Germany.
Objectives: To determine the incidence and subsequent complications of internal jugular vein (IJV) thrombosis after cannulation performed during cardiopulmonary bypass (CPB) to ensure adequate venous drainage during minimally invasive cardiac surgery.
Design: Single-center observational trial SETTINGS: Intensive care postoperative monitoring of cardiac surgery patients and diagnosis of IJV thrombi at a university tertiary hospital during the 13-month study period from December 1, 2022, to January 11, 2024.
Participants: 44 patients undergoing catheterization of the IJV for total CPB.
The risk of retinal detachment following Boston Keratoprosthesis Type 1 Implantation: Insights from a Retrospective case review.
Am J Ophthalmol
September 2025
Department of Ophthalmology, Université de Montréal, Montréal, Québec, Canada.
Purpose: To evaluate the incidence, risk factors, management strategies, and visual outcomes of retinal detachment (RD) following Boston Keratoprosthesis Type 1 (KPro) implantation.
Design: Single-center, retrospective observational case series.
Methods: Medical records of 157 eyes from 122 adult patients who underwent Boston Type 1 KPro implantation at a tertiary care center between 2008 and 2022 were reviewed.
Retrospective analysis of discharge antibiotic selection and 30-day readmission rate for community acquired pneumonia.
Infect Dis Now
September 2025
University of Missouri-Kansas City School of Pharmacy, 2464 Charlotte Street, Kansas City, MO 64108, USA; Centerpoint Medical Center, 19600 East 39th Street, Independence, MO 64057, USA. Electronic address:
Purpose: This study evaluates 30-day community-acquired pneumonia (CAP) readmission rates dependent on discharge antibiotic selection.
Patients And Methods: This is a retrospective, single-center, observational study of patients discharged with a diagnosis of CAP from July 1st, 2022 through June 30th, 2023. Patients included those empirically treated with ceftriaxone plus azithromycin and with documentation of discharge antibiotics.
Diagnostic Value of Centrally Restricted Diffusion in Differentiating Radiation Necrosis from Tumor Progression in Brain Metastases: A Single-Center Observational Study.
J Neuroradiol
September 2025
Department of Neuroradiology, East Group Hospital, Hospices Civils de Lyon. 59 Bd Pinel, 69500, Bron, France; CREATIS Laboratory, CNRS UMR 5220, INSERM U1294, Claude Bernard Lyon I University. 7 avenue Jean Capelle O, 69100, Villeurbanne, France. Electronic address:
Background: Distinguishing radiation necrosis (RN) from true progression (TP) in irradiated brain metastases is challenging. We evaluated the diagnostic performance of the centrally restricted diffusion sign on diffusion-weighted imaging (DWI).
Methods: From August 2014 to August 2024, we screened 321 patients with histologically confirmed brain metastases treated with radiation therapy and follow-up MRI for new or enlarging necrotic lesions ≥1 cm.
The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: a real-world retrospective single center study of a surgically treated cohort.
Pituitary
September 2025
Facoltà Di Medicina E Chirurgia, Università Cattolica del Sacro Cuore, Rome, Italy.
Introduction: Pituitary adenomas (PAs) are generally benign neoplasms, though in rare cases may exhibit aggressive behavior. In 2024, the PANOMEN-3 workshop released a new clinical-pathological classification. The objective of this study was to examine the potential of the PANOMEN-3 classification to predict prognosis of PAs and guide treatment in our single center cohort of patients with PAs.
View Article and Find Full Text PDF